Mirxes

Public

SingaporeBiotechhttps://www.mirxes.com

Last Round

IPO Announced

May 23, 2025

Est. Valuation

$1.06B

Total Funding Raised

$322.75M

Company Overview

MiRXES is a healthcare company that develops a diagnostic test platform for the early detection of cancer through microRNA quantification, enabling healthcare professionals to identify the disease at asymptomatic stages.

Sector

Biotech

AI Layer

Application

Keywords

gastric cancer screening blood testblood-based microRNA (miRNA) diagnostic testliquid biopsy for cancer screeningprecision multi-omics services for biopharmamulti-cancer early detection testlung cancer screening blood testAI-driven molecular diagnosticsin-vitro diagnostic (IVD) test kitmiRNA biomarker detection platformclinical sequencing serviceRT-PCR diagnostic test

Mirxes Comps

Public and private peers based on sector, stage, and business model.

Mirxes comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Mirxes Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
IPO Announced	May 23, 2025
Debt	Jan 13, 2025
Series D	Jul 25, 2023
Series C	Jul 8, 2021
Series A	Nov 27, 2018
Seed	Sep 5, 2016

View all Funding Rounds

Mirxes Investors

Notable investors and investment history

Mirxes investors
Investor	Rounds
Singapore Health Management	Seed
CBC Group	Debt
EDBI	Series C
CCB International	Series C
CCB International Capital Limited	IPO
NHH Ventures	Series D
Keytone Ventures	Series C

View all Investors

Mirxes Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Mirxes Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersSingapore

Employee Range153

Year Founded2014

Last FundingMay 23, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.